2018
Cost-Effectiveness Analyses of the 21-Gene Assay in Breast Cancer: Systematic Review and Critical Appraisal.
Wang SY, Dang W, Richman I, Mougalian SS, Evans SB, Gross CP. Cost-Effectiveness Analyses of the 21-Gene Assay in Breast Cancer: Systematic Review and Critical Appraisal. Journal Of Clinical Oncology 2018, 36: 1619-1627. PMID: 29659329, PMCID: PMC5978470, DOI: 10.1200/jco.2017.76.5941.Peer-Reviewed Original ResearchConceptsCost-effectiveness analysisChemotherapy useBreast cancerEarly-stage breast cancerStudy designIncremental cost-effectiveness ratioODX recurrence scoreHigh-risk patientsLow-risk patientsRisk of biasCost-effectiveness ratioCost-effectiveness estimatesIndustry fundingDistant recurrenceIndustry-funded studiesClinical characteristicsTumor characteristicsRecurrence scoreChemotherapy decisionsScore groupClinical practiceSystematic reviewODXPatientsCancer
2012
Physical therapy interventions for knee pain secondary to osteoarthritis: a systematic review.
Wang SY, Olson-Kellogg B, Shamliyan TA, Choi JY, Ramakrishnan R, Kane RL. Physical therapy interventions for knee pain secondary to osteoarthritis: a systematic review. Annals Of Internal Medicine 2012, 157: 632-44. PMID: 23128863, DOI: 10.7326/0003-4819-157-9-201211060-00007.Peer-Reviewed Original ResearchConceptsLow-strength evidencePhysical therapy interventionsPT interventionsIndividual RCTsAerobic exerciseTherapy interventionPool standardized mean differencesPhysiotherapy Evidence DatabaseRisk of biasCommunity-dwelling adultsStandardized mean differenceMeans of outcomesImproved disabilityKnee painAdverse eventsKnee osteoarthritisNonsurgical treatmentCochrane LibraryPhysical functionEvidence DatabaseLeading causeOutcome measuresSustained benefitPainSynthesis of evidence